Professor ZHOU Caiyun's Clinical Experience in Stage Syndrome Differentiation Treatment of Behcet's Disease

WANG Xin; ZHANG Yu; LYU Xing; LI Shiyu; LI Nannan; ZHOU Caiyun

doi:10.3969/j.issn.1673-7202.2021.09.024

Suggestions

您当前的位置：

首页 >

文章列表页 >

Professor ZHOU Caiyun's Clinical Experience in Stage Syndrome Differentiation Treatment of Behcet's Disease

Previous: The Application of Theories of Spleen and Stomach in Lingnan Orthopedics——Experience of Professor Qin Wang in the Treatment of Arthrom yodynia

Next: LIN Hongsheng's Clinical Experience in the Treatment of Lung Cancer with the Method of Softening Hardness and Dissipating Mass

Professor ZHOU Caiyun's Clinical Experience in Stage Syndrome Differentiation Treatment of Behcet's Disease
1.Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China
DOI：10.3969/j.issn.1673-7202.2021.09.024

扫描看全文

WANG Xin, ZHANG Yu, LYU Xing, et al. Professor ZHOU Caiyun's Clinical Experience in Stage Syndrome Differentiation Treatment of Behcet's Disease[DB/OL].（2023-09-15）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.3969/j.issn.1673-7202.2021.09.024
DOI：

WANG Xin, ZHANG Yu, LYU Xing, et al. Professor ZHOU Caiyun's Clinical Experience in Stage Syndrome Differentiation Treatment of Behcet's Disease[DB/OL].（2023-09-15）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.3969/j.issn.1673-7202.2021.09.024 DOI：

摘要

白塞病是一种以血管炎为基本病理改变的慢性全身性炎症疾病，病变可累及多系统，病情复杂，缠绵难愈。周彩云教授主张中西医结合治疗白塞病，提出了分期辨治的治疗原则，认为“湿热毒邪内蕴、热毒伤络”为本病病机关键，急性活动期关键病机为“湿热毒邪内蕴、热毒伤络”，治疗应以清热解毒、凉血护络为大法，可兼以清热利湿；间歇期病机特点为“脾气亏虚、湿热毒余邪内蕴、络脉受损”，治疗应益气健脾，兼清热解毒利湿、凉血护络。

Abstract

Behcet's disease is a chronic systemic inflammatory disease with vasculitis as the basic pathological change. The disease can affect multiple systems with complex conditions and is very easy to relapse. Professor ZHOU Caiyun advocates integrated Chinese and Western medicine for Behcet's disease. She proposes treatment based on stage differentiation and considers that the essential pathological mechanism is not only dampness-heat toxin amassment but also collaterals injury caused by heat toxin. In acute active phase, the key pathogenesis is dampness heat and pathogenic toxin accumulated in interior and heat-toxicity hurting collateral. The main treatment should be clearing heat and removing toxicity, cooling blood and protecting collaterals, assisted by promoting dieresis. In intermission, the main pathological mechanism is deficiency of spleen qi, remnant dampness-heat toxin, and damaged collaterals, which can be treated by replenishing qi and invigorating spleen, with the main treatment at acute phase as its assistance.

关键词

白塞病分期辨治周彩云经验贝赫切特综合征中医药急性活动期间歇期

Keywords

Behcet's diseaseStaged syndrome differentiation treatmentProfessor ZHOU CaiyunClinical experienceBehçet syndromeTraditional Chinese medicineAcute active phaseIntermission

references

中华医学会风湿病学分会.白塞病诊断和治疗指南[J]. 中华风湿病学杂志, 2011, 15(5): 345-347.

Davatchi F, Shahram F, Chams-Davatchi C, et al. Behcet's disease: from East to West[J]. Clin Rheumatol, 2010, 29(8): 823-833.

Davatchi F, Chams-Davatchi C, Shams H, et al. Behcet's disease: epidemiology, clinical manifestations, and diagnosis[J]. Expert Rev Clin Immunol, 2017, 13(1): 57-65.

Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides[J]. Arthritis Rheum, 2013, 65(1): 1-11.

李超然, 郑文洁.白塞病的免疫遗传学研究进展[J]. 中华风湿病学杂志, 2018, 22(8): 568-572.

Hatemi G, Yazici H. Behcet′s syndrome and micro-organisms[J]. Best Pract Res Clin Rheumatol, 2011, 25(3): 389-406.

陈永, 李亚明, 管剑龙.白塞病的中西医结合病理机制[J]. 中国中医基础医学杂志, 2018, 24(1): 28-30.

张卓莉, 彭劲民, 侯小萌, 等.1996例白塞病患者的临床荟萃分析[J]. 北京医学, 2007, 29(1): 10-12.

Demirelli S, Degirmenci H, Inci S, et al. Cardiac manifestations in Behcet's disease[J]. Intractable Rare Dis Res, 2015, 4(2): 70-75.

Alibaz-Oner F, Karadeniz A, Ylmaz S, et al. Behcet disease with vascular involvement: effects of different therapeutic regimens on the incidence of new relapses[J]. Medicine(Baltimore), 2015, 94(6): e494.

高娜, 韩薇, 慈维苹, 等.白塞病心血管受累患者的临床特点[J]. 中华医学杂志, 2016, 96(19): 1523-1526.

郑文洁.重视白塞病血管病变[J]. 中华风湿病学杂志, 2016, 20(12): 793-795.

Wu X, Li G, Huang X, et al. Behcet's disease complicated with thrombosis: a report of 93 Chinese cases[J] , Medicine(Baltimore), 2014, 93(28): e263.

李南南, 韩淑花, 王鑫, 等.周彩云运用四妙勇安汤加味治疗白塞病经验[J]. 北京中医药, 2017, 36(9): 813-815.

刘珊, 王鑫, 郭颖.周彩云教授治疗白塞病经验浅释[J]. 环球中医药, 2018, 11(9): 1453-1455.

曾安琪, 华桦, 陈朝荣, 等.金银花、山银花抗炎药理作用研究[J]. 中国中药杂志, 2020, 45(16): 3938-3944.

杜叶青, 段治康, 董舒等.基于网络药理学的金银花活性成分抗炎作用机制的研究[J]. 中国药物化学杂志, 2019, 29(2): 96-102.

李静, 陈长勋, 高阳, 等.玄参提取物抗炎与抗动脉硬化作用的探索[J]. 时珍国医国药, 2010, 21(3): 532-534.

李翎熙, 陈迪路, 周小江.玄参化学成分、药理活性研究进展及其质量标志物分析预测[J]. 中成药, 2020, 42(9): 2417-2426.

赵洪伟, 张宁, 庞牧, 等.玄参及其拆分组分对热证大鼠物质与能量代谢的影响[J]. 中药药理与临床, 2017, 33(6): 93-96.

李娜, 曲晓波, 蔺爽, 等.四妙勇安汤对大鼠血栓闭塞性脉管炎的抗炎作用及其机制[J]. 吉林大学学报：医学版, 2013, 39(2): 264-267.

陈亚勇, 于天启.四妙勇安汤加减治疗原发性血小板增多症的临床观察[J]. 中医临床研究, 2018, 10(32): 107-108.

陆小华, 马骁, 王建, 等.赤芍的化学成分和药理作用研究进展[J]. 中草药, 2015, 46(4): 595-602.

纪云飞, 王瑞君, 李晓波.复方四君子汤的化学成分和药理作用研究进展[J]. 中草药, 2016, 47(5): 837-843.

罗予, 张燕, 杜楠楠.味四君子汤对阿司匹林致大鼠胃黏膜损伤的修复作用[J]. 郑州大学学报：医学版, 2011, 46(1): 77-79.

刘继东, 苗嘉芮, 李宁, 等.四君子汤调节脾气虚大鼠能量代谢相关基因的研究[J]. 中华中医药杂志, 2016, 31(3): 985-987.

黄文武, 彭颖, 王梦月, 等.四君子汤及其单味药水煎液对脾虚大鼠肠道菌群的调节作用[J]. 中国实验方剂学杂志, 2019, 25(11): 8-15.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Syndrome Differentiation and Treatment of COVID-19 by Academician Tong Xiaolin:Origin, Innovation, and Development of "Cold-Dampness Plague" Theory

Clinical Experience of Professor Zhang Sheng Sheng in Treating Chronic Diarrhea by'Subduing Activity with Inertia and Combining Activity and Inertia'

Experience on Discussion and Analysis on Application of Cancer Toxicology Theory

Identification and Treatment of Paroxysmal Atrial Fibrillation from Mutual Fanning of Liver Wind and Heart Fire

Seven Proved Cases of Mania

Related Author

No data

Related Institution

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

Beijing University of Chinese Medicine

The Third Affiliated Hospital of Zunyi Medical University

The Second Affiliated Hospital of Shaanxi University of Chinese Medicine

Human Phenome Institute, Fudan University

⁰